ATEROMA 40 MG COM REV CT BL AL/AL X 30

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1037202630107
  • GGREM 542614040002004
  • Código de barras 7898943707147

O que a fonte publica

Detentor do registro
SUPERA FARMA LABORATÓRIOS S.A
Princípios ativos
ATORVASTATINA CÁLCICA
Embalagem
40 MG COM REV CT BL AL/AL X 30
Tipo de produto
Similar
Classe terapêutica
C10A1 - ESTATINAS, INIBIDORES DA REDUTASE HMG-CoA

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:542614040002004
{
  "name": "ATEROMA 40 MG COM REV CT BL AL/AL X 30",
  "holder": "SUPERA FARMA LABORATÓRIOS S.A",
  "stripe": null,
  "barcodes": [
    "7898943707147"
  ],
  "confaz87": true,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "542614040002004",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "43.312.503/0001-05",
  "priceRegime": "Regulado",
  "productName": "ATEROMA",
  "productType": "Similar",
  "hospitalOnly": false,
  "presentation": "40 MG COM REV CT BL AL/AL X 30",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "188.26",
    "icms-12": "213.93",
    "icms-17": "226.82",
    "icms-18": "229.59",
    "icms-19": "232.42",
    "icms-20": "235.33",
    "icms-21": "238.30",
    "icms-22": "241.36",
    "icms-23": "244.49",
    "icms-17.5": "228.19",
    "icms-19.5": "233.86",
    "icms-20.5": "236.81",
    "icms-22.5": "242.92",
    "icms-12-alc": "211.36",
    "icms-17-alc": "224.10",
    "icms-18-alc": "226.83",
    "icms-19-alc": "229.63",
    "icms-20-alc": "232.50",
    "icms-21-alc": "235.44",
    "icms-22-alc": "238.46",
    "icms-23-alc": "241.56",
    "withoutTaxes": "186.00",
    "icms-17.5-alc": "225.46",
    "icms-19.5-alc": "231.06",
    "icms-20.5-alc": "233.96",
    "icms-22.5-alc": "240.00"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "ATORVASTATINA CÁLCICA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "259.50",
    "icms-12": "294.88",
    "icms-17": "312.65",
    "icms-18": "316.47",
    "icms-19": "320.37",
    "icms-20": "324.38",
    "icms-21": "328.47",
    "icms-22": "332.69",
    "icms-23": "337.00",
    "icms-17.5": "314.54",
    "icms-19.5": "322.35",
    "icms-20.5": "326.42",
    "icms-22.5": "334.84",
    "icms-12-alc": "292.19",
    "icms-17-alc": "309.81",
    "icms-18-alc": "313.58",
    "icms-19-alc": "317.45",
    "icms-20-alc": "321.42",
    "icms-21-alc": "325.48",
    "icms-22-alc": "329.66",
    "icms-23-alc": "333.94",
    "withoutTaxes": "257.14",
    "icms-17.5-alc": "311.69",
    "icms-19.5-alc": "319.43",
    "icms-20.5-alc": "323.44",
    "icms-22.5-alc": "331.79"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "ATORVASTATINA CÁLCICA"
  ],
  "therapeuticClass": "C10A1 - ESTATINAS, INIBIDORES DA REDUTASE HMG-CoA",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1037202630107",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "C10A1",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:542614040002004"